DekaBank Deutsche Girozentrale
TEVA icon

DekaBank Deutsche Girozentrale’s Teva Pharmaceuticals TEVA Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.08M Hold
73,580
– – ﹤0.01% 693
2026
Q1 		$2.12M Hold
73,580
– – ﹤0.01% 692
2025
Q4 		$1.14M Hold
73,580
– – ﹤0.01% 854
2025
Q3 		$1.41M Hold
73,580
– – ﹤0.01% 814
2025
Q2 		$1.24M Buy
73,580
+1,453
+2% +$23.4K ﹤0.01% 821
2025
Q1 		$1.06M Sell
72,127
-1,453
-2% -$26K ﹤0.01% 838
2024
Q4 		$1.64M Hold
73,580
– – ﹤0.01% 786
2024
Q3 		$1.28M Sell
73,580
-4,739
-6% -$82.9K ﹤0.01% 840
2024
Q2 		$1.26M Buy
78,319
+6,192
+9% +$95.4K ﹤0.01% 838
2024
Q1 		$1.04M Buy
72,127
+4,131
+6% +$52.1K ﹤0.01% 868
2023
Q4 		$688K Buy
67,996
+1,375
+2% +$12.8K ﹤0.01% 972
2023
Q3 		$670K Buy
66,621
+3,281
+5% +$30.6K ﹤0.01% 950
2023
Q2 		$477K Buy
63,340
+17,630
+39% +$143K ﹤0.01% 1034
2023
Q1 		$398K Buy
45,710
+2,818
+7% +$27.9K ﹤0.01% 1057
2022
Q4 		$392K Buy
42,892
+2,638
+7% +$23K ﹤0.01% 1093
2022
Q3 		$307K Buy
40,254
+2,609
+7% +$23.1K ﹤0.01% 1147
2022
Q2 		$292K Buy
37,645
+1,307
+4% +$11.4K ﹤0.01% 1126
2022
Q1 		$342K Buy
36,338
+2,655
+8% +$22.2K ﹤0.01% 1127
2021
Q4 		$284K Sell
33,683
-121
-0.4% -$1.09K ﹤0.01% 1208
2021
Q3 		$329K Buy
33,804
+4,439
+15% +$41.6K ﹤0.01% 1124
2021
Q2 		$295K Buy
29,365
+4,665
+19% +$49.4K ﹤0.01% 1146
2021
Q1 		$277K Buy
24,700
+1,610
+7% +$18.5K ﹤0.01% 1130
2020
Q4 		$224K Buy
23,090
+949
+4% +$9.09K ﹤0.01% 1168
2020
Q3 		$193K Sell
22,141
-21,484
-49% -$227K ﹤0.01% 1059
2020
Q2 		$524K Buy
43,625
+2,664
+7% +$30.1K ﹤0.01% 798
2020
Q1 		$360K Buy
40,961
+851
+2% +$8.72K ﹤0.01% 818
2019
Q4 		$395K Sell
40,110
-2,858
-7% -$25.5K ﹤0.01% 870
2019
Q3 		$297K Sell
42,968
-142,914
-77% -$1.09M ﹤0.01% 814
2019
Q2 		$1.69M Buy
185,882
+77,895
+72% +$939K 0.01% 666
2019
Q1 		$2.5M Sell
107,987
-1,036
-1% -$18.3K 0.01% 558
2018
Q4 		$1.71M Buy
109,023
+1,036
+1% +$21.2K 0.01% 573
2018
Q3 		$2.5M Sell
107,987
-51,700
-32% -$1.2M 0.01% 571
2018
Q2 		$3.95M Sell
159,687
-7,100
-4% -$145K 0.03% 454
2018
Q1 		$2.84M Sell
166,787
-138,469
-45% -$2.7M 0.02% 501
2017
Q4 		$5.39M Sell
305,256
-4,050
-1% -$60.9K 0.04% 354
2017
Q3 		$5.46M Sell
309,306
-94,982
-23% -$2.14M 0.04% 354
2017
Q2 		$13.3M Buy
404,288
+27,094
+7% +$839K 0.11% 213
2017
Q1 		$12.3M Sell
377,194
-176,391
-32% -$6.02M 0.11% 195
2016
Q4 		$19.9M Buy
553,585
+99,598
+22% +$3.98M 0.21% 110
2016
Q3 		$21M Buy
453,987
+224,070
+97% +$11.7M 0.23% 101
2016
Q2 		$11.6M Buy
229,917
+7,401
+3% +$394K 0.13% 179
2016
Q1 		$11.9M Buy
222,516
+38,227
+21% +$2.24M 0.14% 164
2015
Q4 		$12.2M Buy
184,289
+12,246
+7% +$757K 0.14% 150
2015
Q3 		$9.71M Buy
172,043
+23,690
+16% +$1.54M 0.12% 184
2015
Q2 		$8.77M Sell
148,353
-2,000
-1% -$123K 0.1% 192
2015
Q1 		$9.37M Sell
150,353
-25,190
-14% -$1.46M 0.12% 185
2014
Q4 		$10M Sell
175,543
-5,980
-3% -$333K 0.13% 170
2014
Q3 		$9.75M Buy
181,523
+36,654
+25% +$1.94M 0.13% 160
2014
Q2 		$7.59M Buy
144,869
+3,597
+3% +$184K 0.11% 187
2014
Q1 		$7.46M Buy
141,272
+126,710
+870% +$5.86M 0.12% 177
2013
Q4 		$584K Sell
14,562
-44,654
-75% -$1.76M 0.01% 527
2013
Q3 		$2.23M Buy
+59,216
New +$2.31M 0.04% 304

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

DekaBank Deutsche Girozentrale's TEVA Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 73,580 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #693.

DekaBank Deutsche Girozentrale first reported a position in TEVA in Q3 2013 and has held it in 52 quarters since. The position peaked at $21M in Q3 2016. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • DekaBank Deutsche Girozentrale held 73,580 shares of Teva Pharmaceuticals worth $2.08M as of Q2 2026.
  • DekaBank Deutsche Girozentrale left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #693 holding.
  • DekaBank Deutsche Girozentrale first reported a position in Teva Pharmaceuticals in Q3 2013 and has held it in 52 quarters since.
  • DekaBank Deutsche Girozentrale's Teva Pharmaceuticals position peaked at $21M in Q3 2016.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.